FY2026 EPS Estimates for McKesson Co. Decreased by Analyst (NYSE:MCK)

McKesson Co. (NYSE:MCK - Free Report) - Analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for McKesson in a report issued on Monday, October 7th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $35.93 per share for the year, down from their previous estimate of $36.03. The consensus estimate for McKesson's current full-year earnings is $32.07 per share. Leerink Partnrs also issued estimates for McKesson's FY2028 earnings at $45.42 EPS.

Several other equities analysts also recently issued reports on MCK. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a research note on Wednesday, September 25th. JPMorgan Chase & Co. increased their price target on McKesson from $656.00 to $661.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 21st. StockNews.com lowered McKesson from a "buy" rating to a "hold" rating in a research note on Friday, September 27th. Barclays lifted their price target on McKesson from $596.00 to $616.00 and gave the company an "overweight" rating in a report on Thursday, August 8th. Finally, Leerink Partners cut their price objective on shares of McKesson from $665.00 to $630.00 and set an "outperform" rating on the stock in a report on Monday. Five equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $610.86.

McKesson Trading Up 1.4 %

Shares of NYSE:MCK traded up $6.78 on Wednesday, hitting $501.87. The company had a trading volume of 734,401 shares, compared to its average volume of 809,227. The company has a market cap of $65.21 billion, a PE ratio of 22.28, a PEG ratio of 1.18 and a beta of 0.44. The business has a 50 day moving average of $535.98 and a 200 day moving average of $553.73. McKesson has a 52-week low of $431.35 and a 52-week high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, topping analysts' consensus estimates of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business had revenue of $79.28 billion during the quarter, compared to analysts' expectations of $82.53 billion. During the same period last year, the company posted $7.27 EPS. The company's revenue was up 6.4% on a year-over-year basis.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were given a $0.71 dividend. The ex-dividend date of this dividend was Friday, August 30th. This is a positive change from McKesson's previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a yield of 0.57%. McKesson's dividend payout ratio (DPR) is 12.69%.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 3,753 shares of the firm's stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the sale, the chief executive officer now directly owns 82,339 shares in the company, valued at approximately $51,546,684.17. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.11% of the company's stock.

Institutional Investors Weigh In On McKesson

A number of large investors have recently added to or reduced their stakes in MCK. Steigerwald Gordon & Koch Inc. boosted its position in McKesson by 6.5% in the 3rd quarter. Steigerwald Gordon & Koch Inc. now owns 36,008 shares of the company's stock valued at $17,803,000 after buying an additional 2,204 shares during the last quarter. Sanibel Captiva Trust Company Inc. grew its stake in McKesson by 2.9% during the 3rd quarter. Sanibel Captiva Trust Company Inc. now owns 38,161 shares of the company's stock valued at $18,868,000 after purchasing an additional 1,083 shares in the last quarter. Peddock Capital Advisors LLC increased its holdings in McKesson by 0.3% during the 3rd quarter. Peddock Capital Advisors LLC now owns 7,988 shares of the company's stock worth $3,949,000 after purchasing an additional 25 shares during the last quarter. Tilia Fiduciary Partners Inc. raised its position in shares of McKesson by 4.3% in the 3rd quarter. Tilia Fiduciary Partners Inc. now owns 4,889 shares of the company's stock valued at $2,417,000 after purchasing an additional 203 shares in the last quarter. Finally, Strategic Wealth Partners Ltd. boosted its stake in shares of McKesson by 14.2% during the 3rd quarter. Strategic Wealth Partners Ltd. now owns 660 shares of the company's stock valued at $326,000 after buying an additional 82 shares during the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.